Viatris : VTRS Q1 2026 Earnings Infographic - FINAL

Published: 2026-05-07 07:26:24 ET VTRS

Published on 05/07/2026 at 07:26 am EDT

We delivered a strong first quarter, reflecting disciplined execution across our global businesses. Our performance reinforces

the growth trajectory we outlined at our Investor Event in March. We saw continued momentum in key markets like Greater China and North America, progressed on launches and advanced our pipeline with multiple

near-term catalysts. We expect to generate significant cash in 2026, providing flexibility to execute against our balanced capital allocation framework. Based on our strong start, we believe we are well positioned to deliver on our full-year guidance, and we remain focused on building a more durable, higher-quality growth profile for Viatris."

Total Revenues

$3.5B

Adjusted EBITDA*

$1.0B

Adjusted EPS*

$0.59

Free Cash Flow*

Ex. Transaction and Restructuring Costs

$459M

SCOTT A. SMITH

Chief Executive Officer

tion

Q1 performance ahead of our expectations, with 3% total revenue growth, 10% adjusted EBITDA growth, and 14% adjusted EPS growth operationally

Strong commercial execution across our global portfolio, led by Greater China and North America

Received approval and launched Effexor® for generalized anxiety disorder in Japan

Cenerimod SLE Phase 3 trials fully enrolled; Selatogrel Phase 3 enrollment on track

Returned $140M of capital to shareholders through dividends paid

On track to deliver identified cost savings, while reinvesting in the business to support future growth

2026 Strategic Priorities Execution

Delivering on Our /0/6 Strategic Priorities

Deliver strong financial performance

Drive commercial execution, including launche

Advance our pipeline, including regulatory decisions for six product candidates

Execute disciplined and balanced capital alloca

Target accretive in-market business development

Evolve our organization and modernize for future growth

Highlights

* Non-GAAP Financial Measure. For more information about Non-GAAP financial measures and reconciliations to the closest U.S. GAAP financial measure, as well as risks related to forward-looking statements, please read our First-Quarter 2026 Financial Results press release on our website.

(1) Q1 2026 Free Cash Flow was $348M. Excluding the impact of transaction-related and restructuring-related costs of $111M, Q1 2026 Free Cash Flow was $459M.

Viatris.com LinkedIn @ViatrisInc @ViatrisIncYouTube

Disclaimer

Viatris Inc. published this content on May 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2026 at 11:22 UTC.